Loading…
Marker Therapeutics, Inc. is projected to rise to $1.55 by 2027, a +2% move from its current price of $1.51. MRKR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.46 | $1.51 | $1.57 | +0.09% |
| Jul 13 | $1.44 | $1.51 | $1.59 | +0.18% |
| Jul 14 | $1.42 | $1.51 | $1.61 | +0.26% |
| Jul 15 | $1.41 | $1.52 | $1.63 | +0.35% |
| Jul 16 | $1.40 | $1.52 | $1.65 | +0.44% |
| Jul 17 | $1.39 | $1.52 | $1.66 | +0.53% |
| Jul 18 | $1.38 | $1.52 | $1.67 | +0.62% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.38 | $1.52 | $1.67 | +0.62% |
| Week 2 | $1.33 | $1.53 | $1.75 | +1.24% |
| Week 3 | $1.30 | $1.54 | $1.82 | +1.86% |
| Week 4 | $1.28 | $1.55 | $1.88 | +2.49% |
| Week 5 | $1.26 | $1.56 | $1.93 | +3.13% |
| Week 6 | $1.24 | $1.57 | $1.98 | +3.76% |
| Week 7 | $1.22 | $1.58 | $2.03 | +4.40% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company focused on T cell based therapies for hematological malignancies and solid tumor indications in the United States. The MAR-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets.
Marker Therapeutics develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc.
in October 2018. Marker Therapeutics was founded in 1999 and is headquartered in Houston, Texas.
Marker Therapeutics, Inc. (MRKR) is a healthcare stock trading at $1.51. It has a market cap of $25.18M and ranks 4784. The stock’s price trajectory is laid out in a year-by-year forecast, with a path from a neutral rating in 2026 toward bullish momentum in later years.
The forecast shows an average price near $1.51 in 2026, rising to higher levels through 2029 and beyond, with substantial upside by 2050. The forecast also notes a high level of volatility, with an annualized volatility of 70%.
A major floor 25.2% below — a decisive break under it would weaken the trend.
The nearest floor, 13.2% below — buyers have tended to step in here.
The nearest ceiling, 11.3% above — a clean break opens room to run.
A major ceiling 23.8% above — clearing it would confirm fresh momentum.
Key MRKR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MRKR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.57 | Sell | $1.55 | Sell |
| MA 10 | $1.50 | Buy | $1.51 | Sell |
| MA 20 | $1.43 | Buy | $1.47 | Buy |
| MA 50 | $1.44 | Buy | $1.45 | Buy |
| MA 100 | $1.45 | Buy | $1.45 | Buy |
| MA 200 | $1.38 | Buy | $1.48 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.21 | Neutral |
| Stoch RSI (14) | 46.56 | Neutral |
| CCI (20) | 63.93 | Neutral |
| Williams %R (14) | -45.95 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 10.22 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 54.05 | Neutral |
| TRIX (15) | 0.12 | Buy |
| Awesome (5,34) | 0.13 | Buy |
| Ultimate (7,14,28) | 56.13 | Neutral |
| Momentum (10) | 0.20 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 1.62 | Sell |
| ADX (14) | 16.32 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is bullish. RSI14 is 50, indicating a balanced momentum near the midpoint. The stock trades above the 50-day and 200-day moving averages, with SMA50 at $1.44 and SMA200 at $1.38.
Immediate support is at $1.31 and resistance at $1.68, suggesting a near-term trading range around these levels. The 30-day price range runs from $1.19 to $1.92, reflecting the current volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.24 | $1.51 | $2.04 | 0% | Neutral | |
| $1.19 | $1.55 | $2.14 | +2% | Neutral | |
| $1.33 | $1.80 | $2.61 | +19% | Neutral | |
| $1.78 | $2.47 | $3.72 | +64% | Bullish | |
| $1.71 | $2.44 | $3.79 | +62% | Bullish | |
| $1.61 | $2.37 | $3.77 | +57% | Bullish | |
| $1.68 | $2.53 | $4.13 | +68% | Bullish | |
| $1.64 | $2.52 | $4.21 | +67% | Bullish | |
| $1.93 | $3.04 | $5.17 | +102% | Bullish | |
| $2.23 | $3.60 | $6.23 | +138% | Bullish | |
| $2.57 | $4.58 | $8.54 | +203% | Bullish | |
| $3.84 | $8.19 | $17.01 | +442% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.24 | $1.51 | $1.80 | +0.00% |
| August 2026 | $1.31 | $1.56 | $1.91 | +3.02% |
| September 2026 | $1.36 | $1.64 | $2.04 | +5.17% |
| October 2026 | $1.32 | $1.61 | $2.03 | -1.90% |
| November 2026 | $1.27 | $1.56 | $1.99 | -3.05% |
| December 2026 | $1.29 | $1.58 | $2.04 | +1.81% |
Click any year to see its month-by-month MRKR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect MRKR to range from $1.24 to $2.04 through 2026. The $1.51 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The MRKR price prediction for 2027 points to an average of $1.55 (low $1.19, high $2.14) — a potential gain of +2% on today's $1.51. Price action looks broadly range-bound.
In 2028, MRKR is projected to trade between $1.33 and $2.61, averaging $1.80 — a potential gain of +19% from today's $1.51. That is up +16% on the projected 2027 average. A consolidation phase looks the most probable path here.
Marker Therapeutics, Inc.'s 2029 outlook centres on $2.47, within a $1.78 to $3.72 range. That is up +38% on the projected 2028 average. That marks a +64% change versus current levels. Momentum favours further upside here.
By 2030, MRKR could reach as high as $3.79, with a base case around $2.44 and support toward $1.71 — roughly +62% from $1.51. Buyers look set to stay in control over this stretch.
Expect MRKR to range from $1.61 to $3.77 through 2031. The $2.37 average target implies a +57% move from current prices. That is -3% versus the projected 2030 average. Momentum favours further upside here.
The MRKR price prediction for 2032 points to an average of $2.53 (low $1.68, high $4.13) — a potential gain of +68% on today's $1.51. Buyers look set to stay in control over this stretch.
In 2033, MRKR is projected to trade between $1.64 and $4.21, averaging $2.52 — a potential gain of +67% from today's $1.51. That is 0% versus the projected 2032 average. Momentum favours further upside here.
Marker Therapeutics, Inc.'s 2034 outlook centres on $3.04, within a $1.93 to $5.17 range. That is up +21% on the projected 2033 average. That marks a +102% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, MRKR could reach as high as $6.23, with a base case around $3.60 and support toward $2.23 — roughly +138% from $1.51. Momentum favours further upside here.
Expect MRKR to range from $2.57 to $8.54 through 2040. The $4.58 average target implies a +203% move from current prices. That is up +27% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The MRKR price prediction for 2050 points to an average of $8.19 (low $3.84, high $17.01) — a potential gain of +442% on today's $1.51. Momentum favours further upside here.
Investing $1,000 in MRKR today (≈ 662.251656 MRKR) could be worth
$5,421.31
+$4,421.31 (+442%) by 2050 · US Dollar
Based on the average projected MRKR price of $8.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MRKRwould be worth at today's price.
$1,000 invested in MRKR on Jul 10, 2025 (≈ 555.55557 MRKR) would be worth
$838.89
-$161.11 (-16.1%) today · 0.84× · US Dollar
Based on a MRKR entry price of $1.8 vs. today's $1.51.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.47 | $1,027.21 | +2.7% |
| 1 month ago | $1.43 | $1,055.94 | +5.6% |
| 3 months ago | $1.75 | $862.86 | -13.7% |
| 6 months ago | $1.83 | $825.14 | -17.5% |
| 1 year ago | $1.8 | $838.89 | -16.1% |
| All time (5.0y) ago | $25.2 | $59.92 | -94.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MRKR forecast.
Our base-case forecast reaches $3.00 around 2034.
Implied market cap at $3.00: $50.02M
The multi-year forecast shows meaningful upside in the years ahead. For 2029, the min is $1.78, the avg is $2.47, the max is $3.72, with a forecasted ROI of 63.6 and bullish sentiment. In 2030, the min is $1.71, the avg is $2.44, the max is $3.79, with a forecasted ROI of 61.8 and bullish sentiment.
By 2040, the min is $2.57, the avg is $4.58, the max is $8.54, with a forecasted ROI of 203.3 and bullish sentiment. By 2050, the min is $3.84, the avg is $8.19, the max is $17.01, with a forecasted ROI of 442.1 and bullish sentiment. These figures indicate substantial upside potential over the long term, but they come with high volatility, as indicated by an annualized volatility of 70%.
Tap a question to reveal the answer.
2030 min $1.71, avg $2.44, max $3.79; ROI 61.8; sentiment BULLISH.
Forecasts show bullish sentiment from 2029 onward, with 2029 avg $2.47, 2050 avg $8.19 and max $17.01, and a long-run ROI up to 442.1. Note the high volatility at 70% annualized.
Yes. The 2050 forecast lists an average of $8.19 and a max of $17.01, with a min of $3.84, indicating the $8 level is in range within the forecast.
Current price is $1.51. The 30-day range is $1.19 to $1.92.
Market cap is $25.18M and the rank is 4784.
Marker Therapeutics, Inc. Community Discussion
0Share your Marker Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.